| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |